Dudley AC., Shih SC., Cliffe AR., Hida K. and Klagsbrun M.: Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer, 99(1), 118-125, 2008.
Hata H., Kitamura T., Higashino F., Hida K., Yoshida K., Ohiro Y., Totsuka Y., Kitagawa Y. and Shindoh M.: Expression of E1AF, and ets-oncogene transcription factor, expression highly correlates with malignant phenotype of malignant melanoma through upregulating membrane-type-1 matrix metalloproteinase gene. Oncol Rep, 19(5), 1093-1098, 2008
*Hida K., Hida Y. and Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies. Cancer Sci. 99 (3), 459-466, 2008
Amin D., Hida K., Bielenberg D. and Klagsbrun M.:Expression of epidermal growth factor (EGF) receptor but not ErbB3 in Tumor endothelial cells coincides with responsiveness to EGF and sensitivity to EGFR kinase inhibitors. Cancer Res., 66 (4), 2173-2180, 2006
*Hida K.. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities. Cancer Res, 65 (7), 1-4, 2005
Hida K., Hida Y., Amin D., Flint A., Panigrahy D., Morton C. and Klagsbrun M.: Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res., 64(22), 8249-8255, 2004 〔PDF〕
Shindoh M., Adachi M., Higashino F., Yasuda M., Hida K., Nishioka K., Takayama S., Reed J.C., Imai K., Totsuka Y. and Kohgo T.:BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma. Oral Oncol, 36(5), 444-449, 2000
Hanzawa M., Shindoh M., Higashino F., Yasuda,M., Hida K., Kohgo T., Nakamura M., Notani K., Totsuka Y., Yoshida K. and Fujinaga K.: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma (SCC) cell invasion by activating matrix metalloproteinase genes. Carcinogenesis, 21(6), 1079-1085, 2000
Hida K., Shindoh M., Yoshida K., Yasuda M., Hanzawa M., Funaoka K., Kohgo T., Amemiya A., Totsuka Y. and Fujinaga K.: Antisense E1AF transfection restrains oral cancer invasion by reducing MMPs activities. Am J Pathol, 150, 2125-2132, 1997
Hida K., Shindoh M., Yoshida K., Kudoh A., Funaoka K., Kohgo T., Fujinaga K. and Totsuka Y.: Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinomas. Oral Oncol, 33(6), 426-430, 1997
Funaoka K., Shindoh M.,Yoshida K.,Hanzawa M., Hida K.,Nishikata S., Totsuka Y. and Fijinaga K.: Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF, Biochem Biophys Res Commun, 236(1), 79-82, 1997
Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M., Hida K., Kohgo T, Amemiya A., Yoshida K. and Fujinaga K.: Correlated expression of matrix metalloproteinases and ets-family transcription factor E1A-F in invasive oral-squamous-cell-carcinoma-derived cell lines. Am J Pathol, 148(3), 693-700, 1996.